(Q45089646)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

9 December 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Effects of a new phosphodiesterase enzyme type V inhibitor (UK 343-664) versus milrinone in a porcine model of acute pulmonary hypertension (English)

1 reference

9 December 2017

1 reference

Felipe Urdaneta

1

1 reference

9 December 2017

Jessica L Willert

2

1 reference

9 December 2017

Thomas Beaver

3

1 reference

9 December 2017

Bhiken Naik

4

1 reference

9 December 2017

David S Kirby

5

1 reference

9 December 2017

Emilio B Lobato

6

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

The Annals of Thoracic Surgery

9 December 2017

1 reference

9 December 2017

78

1 reference

9 December 2017

4

1 reference

9 December 2017

1433-1437

1 reference

The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide

9 December 2017

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Combination of inhaled nitric oxide with i.v. nitroglycerin or with a prostacyclin analogue in the treatment of experimental pulmonary hypertension.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Cyclic nucleotide phosphodiesterases in the human lung

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Cyclic GMP phosphodiesterase-5: target of sildenafil

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

The toxicology of inhaled nitric oxide

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Nitric oxide: physiology and pharmacology

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Sildenafil can increase the response to inhaled nitric oxide.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Combination therapy with inhaled nitric oxide and intravenous dobutamine during pulmonary hypertension in the rabbit

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Inhaled nitric oxide: therapeutic applications in cardiothoracic surgery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Treatment of acute pulmonary hypertension with inhaled nitric oxide.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E(1) during heart transplantation.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Sildenafil (viagra) facilitates weaning of inhaled nitric oxide following placement of a biventricular-assist device

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ATHORACSUR.2004.04.039

Identifiers

DOI

10.1016/J.ATHORACSUR.2004.04.039

1 reference

9 December 2017

1 reference